Zeitschriftenaufsatz | 2023 Open Access

Oncogenic TYK2P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.

Autor:in

Woess, Katharina; Macho-Maschler, Sabine; Van Ingen Schenau, Dorette S; Butler, Miriam; Lassnig, Caroline; Valcanover, Daniel; Poelzl, Andrea; Meissl, Katrin; Maurer, Barbara; Brandstoetter, Tania; Vogl, Claus; Koren, Anna; Kubicek, Stefan; Orlova, Anna; Moriggl, Richard; Strobl, Birgit; Sexl, Veronika; Van Leeuwen, Frank N; Kuiper, Roland P; Mueller, Mathias

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Müller, Mathias; Vogl, Claus; Orlova, Anna; Lassnig, Caroline; Strobl, Birgit; Sexl, Veronika; Macho-Maschler, Sabine

Journal

Haematologica / The Hematology Journal

Schlagwörter

ACUTE LYMPHOBLASTIC-LEUKEMIA; JAK-STAT PATHWAY; CELL-CYCLE; PRECLINICAL CHARACTERIZATION; SELECTIVE INHIBITOR; ACTIVATION; CANCER; MUTATIONS; JAK/STAT; LESIONS

Dokumententyp

Originalarbeit

CC Lizenz

CCBYNC

Open Access Type

Gold

ISSN/eISSN

0390-6078 - 1592-8721

DOI

10.3324/haematol.2021.279848

WoS ID

WOS:000989538800013

PubMed ID

35021603

Repository Phaidra

o:2234